Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Madrigal Pharmaceuticals Inc (MDGL)

374 + Investors. Track Smart Money conviction in MDGL. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -9
Streak
1Q ▼
Buyers last Q
50%

Smart Money Signals — MDGL

Based on 379 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their MDGL positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (98% of max)

98% of all-time peak
379 hedge funds hold MDGL right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +19% more funds vs a year ago

fund count last 6Q
+61 new funds entered over the past year (+19% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 50% buying

201 buying203 selling
Last quarter: 201 funds bought or added vs 203 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-21 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 41 → 83 → 86 → 65. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

48% of holders stayed for 2+ years

■ 48% conviction (2yr+) ■ 25% medium ■ 28% new
181 out of 379 hedge funds have held MDGL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
📈

Growing discovery — still being found

70 → 41 → 83 → 86 → 65 new funds/Q
New funds entering each quarter: 41 → 83 → 86 → 65. A growing number of institutions are discovering MDGL each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 55% veterans vs 30% newcomers

■ 55% veterans ■ 15% 1-2yr ■ 30% new
Entry-cohort mix of 403 holders: 221 (55%) are 2+ year veterans, 60 entered 1–2 years ago, and 122 (30%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 40% AUM from top-100 funds

40% from top-100 AUM funds
58 of 374 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in MDGL. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.0
out of 10
Moderate Exit Risk
Exit risk score 4.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — MDGL

In 2026 Q1, 201 hedge funds were net buyers of MDGL (65 opened a new position, 136 added to an existing one), while 203 reduced or exited (129 trimmed, 74 sold completely) — a 50% buyer ratio, indicating a slight buying edge. 40% of total institutional value in MDGL is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -9 funds (more exits than new entries). Total institutional holders: 379.

Hedge Fund Ownership: MDGL

How many hedge funds hold MDGL — quarterly history vs. share price
Quarterly hedge fund ownership of MDGL vs. share price

Market Analysis: MDGL

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: MDGL

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Madrigal Pharmaceuticals Inc (MDGL) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much MDGL has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 46d ago
MDGL
-5.5%
XLV
+5.5%

MDGL outperformed XLV by -11.0% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 1d ago
MDGL
+0.0%
XLV
+0.0%

Since the filing became public, MDGL outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

31 top-rated funds 4 high-conviction
Consensus
6.5
/ 10
breadth
×
Elite
3.7
/ 10
conviction
Hedge Fund Positioning: MDGL
2026 Q2 Stats Unlock in 4 days 374 + Investors

Track Smart Money conviction in MDGL. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 374 387 -3.36%
13F Shares 25M 24M 0.82%
Total Value $12.57B $14.03B -10.43%
New Positions 64 86 -22
Increased Positions 128 137 -9
Closed Positions 77 46 +31
Reduced Positions 124 112 +12
Total Calls 15 13 15.38%
Total Puts 14 14 -
PUT/CALL Ratio 0.93 1.08 Neutral

Statistics: MDGL

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

374 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in MDGL. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 MDGL holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Paulson & CO. INC. 27.94% 1,340,020 $719.5M
2 Rtw Investments, LP 9.14% 1,993,687 $1.07B
3 Avoro Capital Advisors LLC 8.84% 1,833,333 $984.4M
4 Jones Hill Capital LP 6.00% 52,545 $28.2M
5 Baker BROS. Advisors LP 5.77% 2,143,131 $1.15B
6 Rock Springs Capital Management LP 4.59% 174,999 $94.0M
7 Tri Locum Partners LP 4.51% 68,273 $36.7M
8 683 Capital Management, LLC 2.37% 90,000 $48.3M
9 Nan Fung Group Holdings Ltd 2.32% 5,672 $3.0M
10 Cannon Global Investment Management, LLC 2.28% 1,500 $805K
11 Armistice Capital, LLC 1.89% 288,000 $154.6M
12 PFM Health Sciences, LP 1.35% 29,313 $15.7M
13 Sphera Funds Management LTD. 1.22% 17,419 $9.4M
14 Affinity Asset Advisors, LLC 0.97% 40,000 $21.5M
15 EULAV Asset Management 0.89% 52,000 $27.9M
16 Knott David M Jr 0.85% 3,000 $1.6M
17 Vestal Point Capital, LP 0.82% 65,000 $34.9M
18 Arrowpoint Investment Partners (Singapore) Pte. Ltd. 0.69% 5,865 $3.1M
19 Hood River Capital Management LLC 0.66% 169,084 $90.8M
20 Tao Capital Management LP 0.58% 21,000 $11.3M
21 Integral Health Asset Management, LLC 0.53% 25,000 $13.4M
22 Alpine Global Management, LLC 0.53% 6,033 $3.2M
23 William Blair Investment Management, LLC 0.52% 324,123 $174.0M
24 JGP Global Gestao de Recursos Ltda. 0.51% 433 $232K
25 Erste Asset Management GmbH 0.45% 110,210 $58.1M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Madrigal Pharmaceuticals Inc (MDGL)

What does the Smart Money Trend signal show for MDGL?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their MDGL positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for MDGL?

Slight buying edge — 50% buying: Last quarter: 201 funds bought or added vs 203 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for MDGL holders?

Elite ownership — 40% AUM from top-100 funds: 58 of 374 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in MDGL. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held MDGL?

48% of holders stayed for 2+ years: 181 out of 379 hedge funds have held MDGL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Madrigal Pharmaceuticals Inc (MDGL) following the 2026 Q2 hedge fund 13F filings?

As of today, MDGL has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), MDGL has gained -5.5% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →